Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

Trial Profile

Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

Phase of Trial: Phase I

Latest Information Update: 17 Aug 2016

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Tuberous sclerosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Aug 2016 Status changed from recruiting to completed.
    • 03 Sep 2015 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016 as reported by
    • 03 Sep 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Sep 2016 as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top